Academics Back Illumina's Grail Buy Against FTC Challenge

By Bryan Koenig (October 27, 2021, 9:12 PM EDT) -- A group of antitrust, patent and economics academics want to back Illumina's $8 billion reacquisition of Grail against a Federal Trade Commission in-house merger challenge, arguing in a proposed amicus brief that the FTC is turning on its head the governing logic of vertical mergers.

The 23 academics from institutions such as Emory, the University of Southern California, George Mason, Harvard, the University of Missouri and Northwestern argued FTC complaint counsel do not have a "sound understanding of this transaction," which staffers want an agency administrative law judge to undo based on concerns that Illumina could leverage its DNA-sequencing technology to...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!